NCT04540536View on ClinicalTrials.gov

Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
Diabetes Mellitus, Type 1Noncompliance, Patient
Interventions
OTHER

Continuous Glucose Monitoring

Participants will be provided with a Dexcom G6 continuous glucose monitor for the duration of the study.

OTHER

Secure texting

A secure platform (TigerConnect) will be used for three-way communication between parents, participants, and clinical personnel

Trial Locations (2)

75390

Childrens Medical Center, Dallas

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT04540536 - Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes | Biotech Hunter | Biotech Hunter